Henan Lingrui Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 600285.SS

Henan Lingrui Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2023: USD 0.00

Henan Lingrui Pharmaceutical Co., Ltd. Goodwill is USD 0.00 for the year ending December 31, 2023, a 0.00% change year over year. Goodwill is the value attributed to intangible assets, such as brand reputation or customer relationships, acquired in a business combination.

Henan Lingrui Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2022 was USD 0.00, a 0.00% change year over year.
Henan Lingrui Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2021 was USD 0.00, a 0.00% change year over year.
Henan Lingrui Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2020 was USD 0.00, a -100.00% change year over year.
Henan Lingrui Pharmaceutical Co., Ltd. Goodwill for the year ending December 31, 2019 was USD 71.80 K, a -1.24% change year over year.

Key data

Date	Goodwill	Total Assets	Current Liabilities	Total Non-Current Liabilities

Shanghai Stock Exchange: 600285.SS

Henan Lingrui Pharmaceutical Co., Ltd.

CEO	Mr. Wei Xiong
IPO Date	Oct. 18, 2000
Location	China
Headquarters	No.666 Jiangjun Road
Employees	2,530
Sector	Healthcare
Industries Pharmaceuticals 3D Printing Cosmetics Drugstores & Retail Pharmacies Eyewear Glass Personal Care Plastics

Description

Henan Lingrui Pharmaceutical Co., Ltd. produces and sells medicines in China. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, tinctures, etc. covering approximately 100 product varieties. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, Shenqi Hypoglycemic capsules, and others. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is based in Xinyang, China.

Key trends

Past 5 years